Cohort profile: an observational population-based cohort study on COVID-19 vaccine effectiveness in the Netherlands - the VAccine Study COVID-19 (VASCO).

Autor: Huiberts AJ; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands., Hoeve CE; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands., Kooijman MN; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands., de Melker HE; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands., Hahné SJ; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands., Grobbee DE; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands., van Binnendijk R; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands., den Hartog G; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands., van de Wijgert JH; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands., van den Hof S; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands., Knol MJ; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands mirjam.knol@rivm.nl.

Publikováno v: BMJ open [BMJ Open] 2024 Oct 14; Vol. 14 (10), pp. e085388. Date of Electronic Publication: 2024 Oct 14.

Association between adverse events after COVID-19 vaccination and anti-SARS-CoV-2 antibody concentrations, the Netherlands, May 2021 to November 2022: a population-based prospective cohort study.

Autor: Holwerda MR; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands., Hoeve CE; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands., Huiberts AJ; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands., den Hartog G; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands., de Melker HE; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands., van den Hof S; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands., Knol MJ; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.

Publikováno v: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2024 Jun; Vol. 29 (25).

Effectiveness of Omicron XBB.1.5 vaccine against infection with SARS-CoV-2 Omicron XBB and JN.1 variants, prospective cohort study, the Netherlands, October 2023 to January 2024.

Autor: Huiberts AJ; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands., Hoeve CE; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands., de Gier B; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands., Cremer J; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands., van der Veer B; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands., de Melker HE; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands., van de Wijgert JH; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands.; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands., van den Hof S; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands., Eggink D; These authors contributed equally to this article and share last authorship.; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands., Knol MJ; These authors contributed equally to this article and share last authorship.; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands.

Publikováno v: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2024 Mar; Vol. 29 (10).

Effects of COVID-19 vaccination and previous infection on Omicron SARS-CoV-2 infection and relation with serology.

Autor: de Gier B; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands., Huiberts AJ; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands., Hoeve CE; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands., den Hartog G; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.; Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands.; Radboud Center for Infectious Diseases, Radboudumc, Nijmegen, The Netherlands., van Werkhoven H; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., van Binnendijk R; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands., Hahné SJM; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands., de Melker HE; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands., van den Hof S; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands., Knol MJ; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands. Mirjam.knol@rivm.nl.

Publikováno v: Nature communications [Nat Commun] 2023 Aug 09; Vol. 14 (1), pp. 4793. Date of Electronic Publication: 2023 Aug 09.

Effectiveness of bivalent mRNA booster vaccination against SARS-CoV-2 Omicron infection, the Netherlands, September to December 2022.

Autor: Huiberts AJ; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands., de Gier B; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands., Hoeve CE; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands., de Melker HE; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands., Hahné SJ; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands., den Hartog G; Radboud Centre for Infectious Diseases, Radboudumc, Nijmegen, the Netherlands.; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands., van de Wijgert JH; Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht (UMCU), Utrecht, the Netherlands.; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands., van den Hof S; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands., Knol MJ; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands.

Publikováno v: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2023 Feb; Vol. 28 (7).